Desq Long
Sign in

Company

Candel Therapeutics, Inc.

CADL · CIK 0001841387

SEC FORM 4
$620,890.58

Candel Therapeutics, Inc. (CADL)

Sale of 59,379 shares at $10.4564 per share.

Reporting Person Tak Paul Peter · Officer Title Chief Executive Officer · Transaction Code S

Traded Sep 11, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001873905-26-000002 · filed 2026-09-11 · View filing →

SEC FORM 4
$193,750.00

Candel Therapeutics, Inc. (CADL)

Acquisition (code M) of 125,000 shares at $1.55 per share.

Reporting Person Tak Paul Peter · Officer Title Chief Executive Officer · Transaction Code M

Traded Sep 10, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001873905-26-000002 · filed 2026-09-11 · View filing →

SEC FORM 4
$2,539,892.74

Candel Therapeutics, Inc. (CADL)

Sale of 220,866 shares at $11.4997 per share.

Reporting Person Tak Paul Peter · Officer Title Chief Executive Officer · Transaction Code S

Traded Sep 10, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001873905-26-000002 · filed 2026-09-11 · View filing →

SEC FORM 4
$84,000.00

Candel Therapeutics, Inc. (CADL)

Sale of 7,000 shares at $12.00 per share.

Reporting Person Tyagarajan Seshu · Officer Title Chief Technology Officer · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001923794-26-000004 · filed 2026-08-19 · View filing →